Stock Events

Stock Events

MDxHealth SA 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13AugExpected
Q1 2026
Next
-0.17
-0.15
-0.14
-0.12
Expected EPS
-0.1692228712
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow O6C0.MU. It's not an investment recommendation.
NVIDIA
4
NVDA
AMD
3
AMD
Rio Tinto
3
RIO
SBM Offshore N.V
3
SBMO.AS

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap21.22B
Guardant Health operates in the liquid biopsy and cancer diagnostics market, directly competing with MDxHealth's focus on cancer detection and monitoring.
Fulgent Genetics
FLGT
Mkt Cap583.63M
Fulgent Genetics offers comprehensive genetic testing, directly competing with MDxHealth in the genomic diagnostics space.
Myriad Genetics
MYGN
Mkt Cap550.63M
Myriad Genetics specializes in molecular diagnostic tests, including for cancer, competing with MDxHealth's diagnostic tests.
Pacific Biosciences of California
PACB
Mkt Cap484.54M
Pacific Biosciences offers sequencing systems that compete with MDxHealth's technologies for genetic analysis in diagnostics.
Illumina
ILMN
Mkt Cap28.78B
Illumina provides sequencing and array-based solutions for genetic analysis, competing with MDxHealth in the genomic diagnostics market.
Qiagen NV
QGEN
Mkt Cap8.56B
Qiagen offers sample to insight solutions including for cancer, competing with MDxHealth in the field of molecular diagnostics.

About

MDxHealth SA operates as a molecular diagnostics company in Belgium, the Netherlands, Spain, Poland, Italy, the United States, rest of European Union, and internationally. The company develops and commercializes epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. Its tests are based on proprietary genetic, epigenetic, and other molecular technologies, as well as assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The company's product pipeline includes tests for bladder, kidney, and other urologic cancers. Its products include ConfirmMDx, a tissue test for prostate cancer; and SelectMDx, a non-invasive urine test for prostate cancer. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Show more...
CEO
Mr. Michael K. McGarrity
Employees
177
Country
Belgium
ISIN
US58286E1029

Listings

MU
DE
O6C0.MU
STU
DE
O6C0.STU
LSE
GB
0O8G.LSE
STU
DE
O6C1.STU

0 Comments

Share your thoughts

FAQ

What is MDxHealth SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange MDxHealth SA stocks are traded under the ticker O6C0.MU.
When is the next MDxHealth SA earnings date?▼
MDxHealth SA is going to release the next earnings report on August 13, 2026.
What were MDxHealth SA earnings last quarter?▼
O6C0.MU earnings for the last quarter are -0.16 EUR per share, whereas the estimation was -0.12 EUR resulting in a -31.35% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does MDxHealth SA have?▼
As of July 20, 2026, the company has 177 employees.
In which sector is MDxHealth SA located?▼
MDxHealth SA operates in the Health & Wellness sector.
When did MDxHealth SA complete a stock split?▼
MDxHealth SA has not had any recent stock splits.
Where is MDxHealth SA headquartered?▼
MDxHealth SA is headquartered in Herstal, Belgium.